CSEMS7 - Henry Friesen Translational Science Lecture: Lipodystrophy: Insights into the genetics and mechanisms of insulin resistance

Saturday, November 29, 2025

13:00 - 14:15 Toronto

Location: Room 206

Speaker(s)

Lindsay T. Fourman, MD

Assistant Professor of Medicine
Massachusetts General Hospital and Harvard Medical School
Boston, Massachusetts, United States

Disclosure(s): Chiesi Farmaceutici: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Theratechnologies: Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) (Ongoing)

Moderator(s)

BP

Breay Paty, MD, FRCPC, Chair, CSEM Stream (he/him/his)

Endocrinologist
Vancouver General Hospital
University of British Columbia
Vancouver, British Columbia, Canada

Disclosure(s): Vertex: Grant/Research Support (Ongoing)

Disclosure(s):

Lindsay T. Fourman, MD: Chiesi Farmaceutici: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Theratechnologies: Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) (Ongoing)

Breay Paty, MD, FRCPC, Chair, CSEM Stream: Vertex: Grant/Research Support (Ongoing)

Learning Objectives: This session will:
1. Describe recent advances in genetics and the pathophysiology of lipodystrophy syndromes.
2. Describe the clinical features of lipodystrophy, and how it relates to insulin resistant syndromes.
3. Describe current and emerging approaches to the management of lipodystrophic and insulin resistance syndromes.